Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo D Müller

Showing results (31-40 of 189) with videos related to

Pageof 19
Sort By:
Peptides|February 8, 2018
Ghrelin regulation of glucose metabolismAnne-Laure Poher, Matthias H Tschöp, Timo D Müller
Biomedicines|October 23, 2021
Chip-Based Sensing of the Intercellular Transfer of Cell Surface Proteins: Regulation by the Metabolic StateGünter A Müller, Matthias H Tschöp, Timo D Müller
American Journal of Physiology. Endocrinology and Metabolism|January 22, 2020
Upregulated phospholipase D activity toward glycosylphosphatidylinositol-anchored proteins in micelle-like serum complexes in metabolically deranged rats and humansGünter A Müller, Matthias H Tschöp, Timo D Müller
The Lancet Regional Health. Europe|November 25, 2024
Recent achievements and future directions of anti-obesity medicationsGerald Grandl, Aaron Novikoff, Xue Liu, et al.
The Lancet Regional Health. Europe|December 27, 2024
Why are we still in need for novel anti-obesity medications?Aaron Novikoff, Gerald Grandl, Xue Liu, et al.
Trends in Endocrinology and Metabolism: TEM|January 17, 2026
Glucose-dependent insulinotropic polypeptide (GIP)Timo D Müller, David A D'Alessio, Jonathan E Campbell
Obesity Facts|January 8, 2010
The 1D1 of burning caloriesTimo D Müller, Nilika Chaudhary, Paul T Pfluger, et al.
Mechanisms of Ageing and Development|July 7, 2020
Age-dependent membrane release and degradation of full-length glycosylphosphatidylinositol-anchored proteins in ratsGünter A Müller, Siegfried Ussar, Matthias H Tschöp, et al.
Molecules (Basel, Switzerland)|February 23, 2020
CB1 Receptor-Dependent and Independent Induction of Lipolysis in Primary Rat Adipocytes by the Inverse Agonist Rimonabant (SR141716A)Günter A Müller, Andreas W Herling, Susanne Wied, et al.
Nature Reviews. Drug Discovery|November 24, 2021
Anti-obesity drug discovery: advances and challengesTimo D Müller, Matthias Blüher, Matthias H Tschöp, et al.
Pageof 19

Showing results (31-40 of 189) with videos related to

Sort By:
Pageof 19
Peptides|February 8, 2018
Ghrelin regulation of glucose metabolismAnne-Laure Poher, Matthias H Tschöp, Timo D Müller
Biomedicines|October 23, 2021
Chip-Based Sensing of the Intercellular Transfer of Cell Surface Proteins: Regulation by the Metabolic StateGünter A Müller, Matthias H Tschöp, Timo D Müller
American Journal of Physiology. Endocrinology and Metabolism|January 22, 2020
Upregulated phospholipase D activity toward glycosylphosphatidylinositol-anchored proteins in micelle-like serum complexes in metabolically deranged rats and humansGünter A Müller, Matthias H Tschöp, Timo D Müller
The Lancet Regional Health. Europe|November 25, 2024
Recent achievements and future directions of anti-obesity medicationsGerald Grandl, Aaron Novikoff, Xue Liu, et al.
The Lancet Regional Health. Europe|December 27, 2024
Why are we still in need for novel anti-obesity medications?Aaron Novikoff, Gerald Grandl, Xue Liu, et al.
Trends in Endocrinology and Metabolism: TEM|January 17, 2026
Glucose-dependent insulinotropic polypeptide (GIP)Timo D Müller, David A D'Alessio, Jonathan E Campbell
Obesity Facts|January 8, 2010
The 1D1 of burning caloriesTimo D Müller, Nilika Chaudhary, Paul T Pfluger, et al.
Mechanisms of Ageing and Development|July 7, 2020
Age-dependent membrane release and degradation of full-length glycosylphosphatidylinositol-anchored proteins in ratsGünter A Müller, Siegfried Ussar, Matthias H Tschöp, et al.
Molecules (Basel, Switzerland)|February 23, 2020
CB1 Receptor-Dependent and Independent Induction of Lipolysis in Primary Rat Adipocytes by the Inverse Agonist Rimonabant (SR141716A)Günter A Müller, Andreas W Herling, Susanne Wied, et al.
Nature Reviews. Drug Discovery|November 24, 2021
Anti-obesity drug discovery: advances and challengesTimo D Müller, Matthias Blüher, Matthias H Tschöp, et al.
Pageof 19